ARCHIVES

Samuel Broder Plans To Leave Celera.

This article is from The Cancer Letter archive.

Vol. 36 No. 32 | September 10, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Encourages IP Chemo For Stage III Ovarian Cancer

January 27, 2006

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

In Brief: Baylor Recruits Scardino, Osborne, 13 Others; Likely To Gain Its Second NCI SPORE Grants

April 30, 1999

Kennedy Bill Leaves National Cancer Act intact, Creates NIH Construction Authority, Senior Service

April 1, 1988

Clearinghouse Finds Five Compounds Pose Risk To Humans

March 2, 1979

KnowMed Buys CancerSource.com Subsidiary Of Jones & Bartlet Publishers.

December 1, 2000